Category: White Paper

  • Whitepaper: Mastering HRMS for Preclinical Toxicology in Diverse Matrices

    Whitepaper: Mastering HRMS for Preclinical Toxicology in Diverse Matrices

    Unlock the highest level of confidence in your preclinical toxicology studies by harnessing the capabilities of High-Resolution Mass Spectrometry (HRMS). While traditional methods lack the sensitivity needed to distinguish subtle differences in mass-to-charge ratios (m/z) between ions, particularly on low-resolution instruments, HRMS provides a substantial advantage, resulting in robust results that surpass conventional methods. Predict […]

  • eBook: Extractables and Leachables, Regulatory Trends & Future Prospects

    eBook: Extractables and Leachables, Regulatory Trends & Future Prospects

    In the ever-evolving landscape of pharmaceuticals, the scrutiny surrounding extractables and leachables has become increasingly pivotal. As regulatory frameworks continually adapt to advancements in technology and scientific understanding, professionals in the pharmaceutical industry find themselves at the intersection of innovation and compliance. This eBook delves into the dynamic world of pharmaceutical extractables and leachables, shedding […]

  • Whitepaper: High Resolution Methods for Clinical Biomarker Validation

    Whitepaper: High Resolution Methods for Clinical Biomarker Validation

    Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays. Gain comparative insights into the superiority of high-resolution methods, and how they overcome central challenges in biomarker assessment and ligand binding assays (LBAs). Examine how regulatory authorities evaluate different techniques in […]

  • Addressing Bioanalytical Method Development Challenges from Preclinical to Clinical Trials

    Addressing Bioanalytical Method Development Challenges from Preclinical to Clinical Trials

    At Sannova, we recognize the intricate and often non-linear nature of R&D and drug development, standing ready to navigate the challenges alongside our clients. One such journey involved a client developing a nanoparticle-bound immunosuppressant. They started with a rat study and contracted a lab to analyze the pegylated protein in their formulation by ELISA. However, […]

  • Videobite: Contract Pharma Sits Down with Jason Apter of Sannova Analytical

    Videobite: Contract Pharma Sits Down with Jason Apter of Sannova Analytical

    Jason Apter discusses the role CROs play in the drug development process, the role of AI, and strategies to accelerate drug development.

  • Managing Customer Experiences – Blending capability with customer needs.

    Managing Customer Experiences – Blending capability with customer needs.

    In the dynamic world of life sciences, mastering customer experience (CX) is paramount. Discover how one can tackle unique challenges and boost revenue through effective CX. Join us for this insightful conversation on leadership, innovation, and prioritizing CX.

  • Get a sneak peek into Sannova Analytical’s digital transformation that will change the CRO landscape

    Get a sneak peek into Sannova Analytical’s digital transformation that will change the CRO landscape

    The new Sannova: the big science, boutique CRO redefining the future of bioanalytical and analytical services. We embarked on a quest for excellence, committed to crafting an unrivaled customer experience hallmarked by quality, speed, and flexibility. The world of pharma & biotech is changing: the surge of biologics & novel modalities; the swift wave of […]

  • Z-factor Approach: Inspiring Confidence

    Z-factor Approach: Inspiring Confidence

    In the world of pharmaceutical clinical trials, success depends on many factors, but one stands out as a crucial cornerstone – robust data to meet regulatory guidelines. The Z-factor is a statistical measure used to evaluate the quality of an assay or screening method. Throughout the drug development process, scientists encounter an accumulation of variability […]

  • Whitepaper: The Ultimate Guide to Nitrosamine Analysis

    Whitepaper: The Ultimate Guide to Nitrosamine Analysis

    Concerns about nitrosamine impurities in foods and drugs is at an all time high. The potential health effects and the associated ethical and legal implications make it imperative for us to address this issue collectively. To assist you in navigating this challenging landscape, we have developed a whitepaper that serves as an authoritative guide to […]

  • Whitepaper: The Essential Roadmap to Drug Development, Unveiling The 3 Pillars of Bioanalytical Success

    Whitepaper: The Essential Roadmap to Drug Development, Unveiling The 3 Pillars of Bioanalytical Success

    Navigating the intricate landscape of regulatory requirements and technical challenges in the pharmaceutical industry can be complex for drug manufacturers. Meeting regulatory standards, achieving accurate quantification, and ensuring sensitivity measurements are vital for your drug development journey. If you find yourself grappling with bioanalytical challenges during the drug development process, rest assured that these obstacles […]